1,366 results on '"LeBlanc, Michael"'
Search Results
2. Bone Biomarkers and Subsequent Survival in Men with Hormone-sensitive Prostate Cancer: Results from the SWOG S1216 Phase 3 Trial of Androgen Deprivation Therapy with or Without Orteronel
3. Putting on “the Helmet of Salvation” and Wielding “the Sword of the Spirit”: Joseph Johnson, Moses Paul, and the Word of God
4. Augmented Learning of Heterogeneous Treatment Effects via Gradient Boosting Trees
5. Quality-of-life outcomes and risk prediction for patients randomized to nivolumab plus ipilimumab vs nivolumab on LungMAP-S1400I.
6. SWOG 1918: A phase II/III randomized study of R-miniCHOP with or without oral azacitidine (CC-486) in participants age 75 years or older with newly diagnosed aggressive non-Hodgkin lymphomas – Aiming to improve therapy, outcomes, and validate a prospective frailty tool
7. Subclonal TP53 mutations are frequent and predict resistance to radioimmunotherapy in follicular lymphoma
8. Abstract 12224: Long Term Mortality in Patients With Low-Risk Myocardial Perfusion Imaging
9. Role of chemotherapy in patients with nasopharynx carcinoma treated with radiotherapy (MAC-NPC): an updated individual patient data network meta-analysis
10. Efficient Management of a Publicly Funded Cancer Clinical Trials Portfolio
11. SWOG S2302, PRAGMATICA-LUNG: A prospective randomized study of ramucirumab plus pembrolizumab (PR) versus standard of care (SOC) for participants previously treated with immunotherapy for stage IV or recurrent non-small cell lung cancer.
12. Trends in Medical Aid in Dying in Oregon and Washington
13. Trends in Medical Aid in Dying in Oregon and Washington.
14. Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patients
15. Cross-validation and Peeling Strategies for Survival Bump Hunting using Recursive Peeling Methods
16. Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol
17. Data‐driven optimization of version 9 American Joint Committee on Cancer staging system for anal cancer.
18. Universal aspects of cohesion
19. Usage of Oregon’s Death With Dignity Act (DWDA).
20. Usage of Oregon's Death With Dignity Act (DWDA).
21. Data‐driven optimization of version 9 American Joint Committee on Cancer staging system for anal cancer
22. Case-only trees and random forests for exploring genotype-specific treatment effects in randomized clinical trials with dichotomous end points
23. Bulk Metallic Glasses Deform via Slip Avalanches
24. Portevin-Le Chatelier mechanism in face-centered-cubic metallic alloys from low to high entropy
25. College Students' Academic Motivation: Differences by Gender, Class, and Source of Payment
26. Distribution of maximum velocities in avalanches near the depinning transition
27. Universal fluctuations and extreme statistics of avalanches near the depinning transtition
28. Five-year outcomes of the S1106 study of R-hyper-CVAD vs R-bendamustine in transplant-eligible patients with mantle cell lymphoma
29. Five-year follow-up of SWOG S0816: limitations and values of a PET-adapted approach with stage III/IV Hodgkin lymphoma
30. Genomic alterations important for the prognosis in patients with follicular lymphoma treated in SWOG study S0016
31. Structures and Assumptions: Strategies to Harness Gene $\times$ Gene and Gene $\times$ Environment Interactions in GWAS
32. An Astyanax mexicanus mao knockout line uncovers the developmental roles of monoamine homeostasis in fish brain
33. The New Brunswick Pharmacy Assessment Clinic: A Novel, Pharmacist-Led, Virtual Collaborative Practice Hub for the Assessment and Prescribing of Nirmatrelvir/Ritonavir for Patients with COVID-19
34. Medicaid Expansion of the Patient Protection and Affordable Care Act and Participation of Patients With Medicaid in Cancer Clinical Trials
35. The New NCI Precision Medicine Trials
36. A Description of Advertisements for Alcohol on LinkNYC Kiosks in Manhattan, New York City : A Pilot Study
37. Case-Only Approach to Identifying Markers Predicting Treatment Effects on the Relative Risk Scale
38. Efficient Management of a Publicly Funded Cancer Clinical Trials Portfolio
39. A Smooth Basis for Clinical Subgroup Analysis
40. The scientific impact and value of large, NCI-sponsored randomized phase III cancer chemoprevention trials
41. Tandem Autologous Hematopoietic Cell Transplantation for Patients with Primary Progressive or Recurrent Hodgkin Lymphoma: A SWOG and Blood and Marrow Transplant Clinical Trials Network Phase II Trial (SWOG S0410/BMT CTN 0703)
42. R-CHOP, radioimmunotherapy, and maintenance rituximab in untreated follicular lymphoma (SWOG S0801): a single-arm, phase 2, multicentre study
43. Adaptive Risk Group Refinement
44. Accounting for All Patients in Waterfall Plots
45. Role of chemotherapy in patients with nasopharynx carcinoma treated with radiotherapy (MAC-NPC): an updated individual patient data network meta-analysis
46. Logic Regression
47. Numerical Clustering of Soil Series Using Profile Morphological Attributes for Potato
48. Allocation of United States Coal Production to Meet Future Energy Needs
49. Adaptive Regression Splines in the Cox Model
50. The Weakening Relationships between Farm and Food Prices
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.